Jane Street’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
+14,424
New +$945K ﹤0.01% 5634
2025
Q4
Sell
-468
Closed -$12.1K 10992
2025
Q3
$12.1K Sell
468
-3,216
-87% -$121K ﹤0.01% 10568
2025
Q2
$212K Sell
3,684
-1,616
-30% -$130K ﹤0.01% 8437
2025
Q1
$574K Sell
5,300
-568
-10% -$49.4K ﹤0.01% 6606
2024
Q4
$279K Sell
5,868
-108
-2% -$6.53K ﹤0.01% 7856
2024
Q3
$587K Buy
5,976
+5,424
+983% +$700K ﹤0.01% 6911
2024
Q2
$90.3K Sell
552
-4,924
-90% -$701K ﹤0.01% 8770
2024
Q1
$835K Buy
5,476
+4,524
+475% +$753K ﹤0.01% 5730
2023
Q4
$299K Sell
952
-3,876
-80% -$1.4M ﹤0.01% 7602
2023
Q3
$2.14M Buy
4,828
+452
+10% +$204K ﹤0.01% 3942
2023
Q2
$1.9M Sell
4,376
-2,644
-38% -$1.49M ﹤0.01% 4237
2023
Q1
$4.17M Buy
7,020
+180
+3% +$101K ﹤0.01% 2698
2022
Q4
$2.76M Buy
6,840
+5,484
+404% +$2.57M ﹤0.01% 3354
2022
Q3
$794K Buy
1,356
+808
+147% +$484K ﹤0.01% 5851
2022
Q2
$299K Sell
548
-752
-58% -$380K ﹤0.01% 7611
2022
Q1
$824K Buy
1,300
+500
+63% +$258K ﹤0.01% 6519
2021
Q4
$540K Hold
800
﹤0.01% 7111
2021
Q3
$524K Buy
+800
New +$683K ﹤0.01% 7192

Other funds holding AGL

Jane Street's AGL Position: Q2 2026 in Review

Jane Street increased its Agilon Health (AGL) stake by 1,709% in Q2 2026, buying an estimated $16.9M and bringing the position to 273,393 shares worth $29.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Jane Street first reported a position in AGL in Q3 2021 and has held it in 18 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Jane Street held 273,393 shares of Agilon Health worth $29.3M as of Q2 2026.
  • Jane Street bought 258,280 Agilon Health shares in Q2 2026, an estimated $16.9M.
  • Agilon Health made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1807 holding.
  • Jane Street first reported a position in Agilon Health in Q3 2021 and has held it in 18 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.